{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:06:55Z","timestamp":1793387215146,"version":"4.5.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Klinikum der Universit\u00e4t M\u00fcnchen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gut Pathog"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Tumor tissues have been shown to host a diverse array of bacteria, suggesting a link between the intratumoral microbiota and the development and progression of cancer. The aim of this explorative study was to perform microbiome analysis in liver tumor and to evaluate its relationship with cancer stage and survival outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We conducted an exploratory study on a cohort of 20 hepatocellular cancer patients from the SORAMIC trial. Patients were divided into curative and palliative groups according to treatment type (local ablation, alone or combined with systemic therapy). The V1-V2 regions of\n                      <jats:italic>16\u00a0S rRNA<\/jats:italic>\n                      were sequenced starting from archival tissues. Amplicon Sequence Variants (ASVs) were taxonomically assigned to the upper (UGI) or lower (LGI) gastrointestinal tract. Bacteria were identified in both tumoral and non-tumoral tissues, showing higher diversity and correlation between diversity and shorter survival in the palliative group (\n                      <jats:italic>S. aureus p<\/jats:italic>\n                      \u2009&lt;\u20090.05;\n                      <jats:italic>B. parvula p<\/jats:italic>\n                      \u2009&lt;\u20090.01;\n                      <jats:italic>A. chinensis p<\/jats:italic>\n                      \u2009&lt;\u20090.01). Both therapy groups were enriched with the genus\n                      <jats:italic>Bacilli<\/jats:italic>\n                      , including\n                      <jats:italic>Streptococcus spp.<\/jats:italic>\n                      ,\n                      <jats:italic>Gemella haemolysans<\/jats:italic>\n                      and\n                      <jats:italic>Helicobacter pylori<\/jats:italic>\n                      , commonly found in UGI. The results suggested that among palliative patients and those with shorter survival,\n                      <jats:italic>G. haemolysans<\/jats:italic>\n                      was more prevalent, while\n                      <jats:italic>H. pylori<\/jats:italic>\n                      was more often found in curative patients with longer survival. However none of the results were significantly different (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&gt;\u20090.05). A higher microbiome biodiversity was associated with an increased number of lesions (\n                      <jats:italic>Hoylesella<\/jats:italic>\n                      ,\n                      <jats:italic>Agathobacter<\/jats:italic>\n                      ,\n                      <jats:italic>Sphingobium<\/jats:italic>\n                      ,\n                      <jats:italic>Cardiobacterium<\/jats:italic>\n                      ,\n                      <jats:italic>Photobacterium<\/jats:italic>\n                      and\n                      <jats:italic>Serratia<\/jats:italic>\n                      , all with\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The presence of bacteria, predominantly from communities of the UGI, suggests their translocation into liver tissue due to impaired barrier function of the upper gut or the ascending pathway along the biliary duct system. The intratumoral prevalence of bacteria with proinflammatory and oncogenic potential suggests their potential role in HCC pathomechanisms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13099-025-00727-y","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T08:51:41Z","timestamp":1752137501000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Profiling of the tumor-associated microbiome in patients with hepatocellular carcinoma"],"prefix":"10.1186","volume":"17","author":[{"given":"Christian","family":"Schulz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramiro","family":"Vilchez-Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"\u00d6cal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Puhr-Westerheide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu Forn\u00e9s","family":"Burnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidrun","family":"Hirner-Eppeneder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Benckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Pech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Reimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Verslype","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Kuhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Ricke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Malfertheiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9710-1662","authenticated-orcid":false,"given":"Marianna","family":"Alunni-Fabbroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"issue":"12","key":"727_CR1","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41568-022-00513-x","volume":"22","author":"MR Fernandes","year":"2022","unstructured":"Fernandes MR, Aggarwal P, Costa RGF, Cole AM, Trinchieri G. Targeting the gut microbiota for cancer therapy. Nat Rev Cancer. 2022;22(12):703\u201322.","journal-title":"Nat Rev Cancer"},{"issue":"18","key":"727_CR2","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","volume":"79","author":"DC Hinshaw","year":"2019","unstructured":"Hinshaw DC, Shevde LA. The tumor microenvironment innately modulates Cancer progression. Cancer Res. 2019;79(18):4557\u201366.","journal-title":"Cancer Res"},{"issue":"9","key":"727_CR3","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1016\/j.cell.2024.03.021","volume":"187","author":"TW Battaglia","year":"2024","unstructured":"Battaglia TW, Mimpen IL, Traets JJH, van Hoeck A, Zeverijn LJ, Geurts BS, et al. A pan-cancer analysis of the Microbiome in metastatic cancer. Cell. 2024;187(9):2324\u2013e3519.","journal-title":"Cell"},{"issue":"10","key":"727_CR4","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/s43018-021-00251-3","volume":"2","author":"N Iida","year":"2021","unstructured":"Iida N, Mizukoshi E, Yamashita T, Yutani M, Seishima J, Wang Z, et al. Chronic liver disease enables gut Enterococcus faecalis colonization to promote liver carcinogenesis. Nat Cancer. 2021;2(10):1039\u201354.","journal-title":"Nat Cancer"},{"issue":"6","key":"727_CR5","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s12032-025-02761-x","volume":"42","author":"NS Kiran","year":"2025","unstructured":"Kiran NS, Chatterjee A, Yashaswini C, Deshmukh R, Alsaidan OA, Bhattacharya S, et al. The Gastrointestinal mycobiome in inflammation and cancer: unraveling fungal dysbiosis, pathogenesis, and therapeutic potential. Med Oncol. 2025;42(6):195.","journal-title":"Med Oncol"},{"issue":"11","key":"727_CR6","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1136\/gutjnl-2024-333378","volume":"73","author":"M Van Hul","year":"2024","unstructured":"Van Hul M, Cani PD, Petitfils C, De Vos WM, Tilg H, El-Omar EM. What defines a healthy gut microbiome? Gut. 2024;73(11):1893\u2013908.","journal-title":"Gut"},{"key":"727_CR7","doi-asserted-by":"crossref","unstructured":"Ebadpour N, Abavisani M, Sahebkar A. Microbiome-driven precision medicine: advancing drug development with pharmacomicrobiomics. J Drug Target. 2025:1\u201316.","DOI":"10.1080\/1061186X.2025.2509283"},{"key":"727_CR8","doi-asserted-by":"publisher","first-page":"102657","DOI":"10.1016\/j.arr.2025.102657","volume":"104","author":"M Abavisani","year":"2025","unstructured":"Abavisani M, Faraji S, Ebadpour N, Karav S, Sahebkar A. Beyond the hayflick limit: how microbes influence cellular aging. Ageing Res Rev. 2025;104:102657.","journal-title":"Ageing Res Rev"},{"key":"727_CR9","doi-asserted-by":"publisher","first-page":"1598009","DOI":"10.3389\/fphar.2025.1598009","volume":"16","author":"SF Yang","year":"2025","unstructured":"Yang SF, Chen XC, Pan YJ. Microbiota-derived metabolites in tumorigenesis: mechanistic insights and therapeutic implications. Front Pharmacol. 2025;16:1598009.","journal-title":"Front Pharmacol"},{"key":"727_CR10","doi-asserted-by":"publisher","first-page":"1287077","DOI":"10.3389\/fmicb.2024.1287077","volume":"15","author":"P Feng","year":"2024","unstructured":"Feng P, Xue X, Bukhari I, Qiu C, Li Y, Zheng P, et al. Gut microbiota and its therapeutic implications in tumor microenvironment interactions. Front Microbiol. 2024;15:1287077.","journal-title":"Front Microbiol"},{"issue":"1","key":"727_CR11","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41392-023-01406-7","volume":"8","author":"LY Zhao","year":"2023","unstructured":"Zhao LY, Mei JX, Yu G, Lei L, Zhang WH, Liu K, et al. Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications. Signal Transduct Target Ther. 2023;8(1):201.","journal-title":"Signal Transduct Target Ther"},{"key":"727_CR12","doi-asserted-by":"publisher","first-page":"775526","DOI":"10.3389\/fimmu.2021.775526","volume":"12","author":"Z Zheng","year":"2021","unstructured":"Zheng Z, Wang B. The gut-Liver Axis in health and disease: the role of gut Microbiota-Derived signals in liver injury and regeneration. Front Immunol. 2021;12:775526.","journal-title":"Front Immunol"},{"issue":"3","key":"727_CR13","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","volume":"72","author":"A Albillos","year":"2020","unstructured":"Albillos A, de Gottardi A, Rescigno M. The gut-liver axis in liver disease: pathophysiological basis for therapy. J Hepatol. 2020;72(3):558\u201377.","journal-title":"J Hepatol"},{"issue":"2","key":"727_CR14","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1136\/gutjnl-2017-315485","volume":"68","author":"V Chew","year":"2019","unstructured":"Chew V, Lee YH, Pan L, Nasir NJM, Lim CJ, Chua C, et al. Immune activation underlies a sustained clinical response to Yttrium-90 radioembolisation in hepatocellular carcinoma. Gut. 2019;68(2):335\u201346.","journal-title":"Gut"},{"issue":"1","key":"727_CR15","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1038\/s41467-021-24010-1","volume":"12","author":"DW Ho","year":"2021","unstructured":"Ho DW, Tsui YM, Chan LK, Sze KM, Zhang X, Cheu JW, et al. Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma. Nat Commun. 2021;12(1):3684.","journal-title":"Nat Commun"},{"issue":"2","key":"727_CR16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.chom.2013.07.007","volume":"14","author":"AD Kostic","year":"2013","unstructured":"Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, Michaud M, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe. 2013;14(2):207\u201315.","journal-title":"Cell Host Microbe"},{"key":"727_CR17","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1146\/annurev-immunol-051116-052133","volume":"35","author":"A Dzutsev","year":"2017","unstructured":"Dzutsev A, Badger JH, Perez-Chanona E, Roy S, Salcedo R, Smith CK, et al. Microbes and Cancer. Annu Rev Immunol. 2017;35:199\u2013228.","journal-title":"Annu Rev Immunol"},{"key":"727_CR18","doi-asserted-by":"publisher","first-page":"612202","DOI":"10.3389\/fimmu.2020.612202","volume":"11","author":"Q Qiu","year":"2020","unstructured":"Qiu Q, Lin Y, Ma Y, Li X, Liang J, Chen Z, et al. Exploring the emerging role of the gut microbiota and tumor microenvironment in Cancer immunotherapy. Front Immunol. 2020;11:612202.","journal-title":"Front Immunol"},{"issue":"1","key":"727_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41392-023-01693-0","volume":"9","author":"Y Cao","year":"2024","unstructured":"Cao Y, Xia H, Tan X, Shi C, Ma Y, Meng D, et al. Intratumoural microbiota: a new frontier in cancer development and therapy. Signal Transduct Target Ther. 2024;9(1):15.","journal-title":"Signal Transduct Target Ther"},{"issue":"7937","key":"727_CR20","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/s41586-022-05435-0","volume":"611","author":"JL Galeano Nino","year":"2022","unstructured":"Galeano Nino JL, Wu H, LaCourse KD, Kempchinsky AG, Baryiames A, Barber B, et al. Effect of the intratumoral microbiota on Spatial and cellular heterogeneity in cancer. Nature. 2022;611(7937):810\u20137.","journal-title":"Nature"},{"issue":"1","key":"727_CR21","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12967-023-03938-6","volume":"21","author":"Y He","year":"2023","unstructured":"He Y, Zhang Q, Yu X, Zhang S, Guo W. Overview of microbial profiles in human hepatocellular carcinoma and adjacent nontumor tissues. J Transl Med. 2023;21(1):68.","journal-title":"J Transl Med"},{"issue":"2","key":"727_CR22","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.cell.2016.03.001","volume":"165","author":"L Zitvogel","year":"2016","unstructured":"Zitvogel L, Ayyoub M, Routy B, Kroemer G. Microbiome and anticancer immunosurveillance. Cell. 2016;165(2):276\u201387.","journal-title":"Cell"},{"key":"727_CR23","doi-asserted-by":"publisher","first-page":"873160","DOI":"10.3389\/fmicb.2022.873160","volume":"13","author":"W Luo","year":"2022","unstructured":"Luo W, Guo S, Zhou Y, Zhao J, Wang M, Sang L, et al. Hepatocellular carcinoma: how the gut microbiota contributes to pathogenesis, diagnosis, and therapy. Front Microbiol. 2022;13:873160.","journal-title":"Front Microbiol"},{"issue":"4","key":"727_CR24","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.ccr.2012.02.007","volume":"21","author":"DH Dapito","year":"2012","unstructured":"Dapito DH, Mencin A, Gwak GY, Pradere JP, Jang MK, Mederacke I, et al. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer Cell. 2012;21(4):504\u201316.","journal-title":"Cancer Cell"},{"issue":"1","key":"727_CR25","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/hep.30036","volume":"69","author":"FR Ponziani","year":"2019","unstructured":"Ponziani FR, Bhoori S, Castelli C, Putignani L, Rivoltini L, Del Chierico F, et al. Hepatocellular carcinoma is associated with gut microbiota profile and inflammation in nonalcoholic fatty liver disease. Hepatology. 2019;69(1):107\u201320.","journal-title":"Hepatology"},{"issue":"4","key":"727_CR26","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1002\/hep.27867","volume":"62","author":"S Wan","year":"2015","unstructured":"Wan S, Kuo N, Kryczek I, Zou W, Welling TH. Myeloid cells in hepatocellular carcinoma. Hepatology. 2015;62(4):1304\u201312.","journal-title":"Hepatology"},{"issue":"2","key":"727_CR27","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/hep.27822","volume":"62","author":"J Ji","year":"2015","unstructured":"Ji J, Eggert T, Budhu A, Forgues M, Takai A, Dang H, et al. Hepatic stellate cell and monocyte interaction contributes to poor prognosis in hepatocellular carcinoma. Hepatology. 2015;62(2):481\u201395.","journal-title":"Hepatology"},{"issue":"1","key":"727_CR28","doi-asserted-by":"publisher","first-page":"10589","DOI":"10.1038\/s41598-021-89963-1","volume":"11","author":"S Komiyama","year":"2021","unstructured":"Komiyama S, Yamada T, Takemura N, Kokudo N, Hase K, Kawamura YI. Profiling of tumour-associated microbiota in human hepatocellular carcinoma. Sci Rep. 2021;11(1):10589.","journal-title":"Sci Rep"},{"key":"727_CR29","doi-asserted-by":"crossref","unstructured":"Liu B, Zhou Z, Jin Y, Lu J, Feng D, Peng R et al. Hepatic stellate cell activation and senescence induced by intrahepatic microbiota disturbances drive progression of liver cirrhosis toward hepatocellular carcinoma. J Immunother Cancer. 2022;10(1).","DOI":"10.1136\/jitc-2021-003069"},{"issue":"1","key":"727_CR30","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41392-022-01159-9","volume":"7","author":"C Xue","year":"2022","unstructured":"Xue C, Jia J, Gu X, Zhou L, Lu J, Zheng Q, et al. Intratumoral bacteria interact with metabolites and genetic alterations in hepatocellular carcinoma. Signal Transduct Target Ther. 2022;7(1):335.","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"727_CR31","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1002\/hep4.1908","volume":"6","author":"D Qu","year":"2022","unstructured":"Qu D, Wang Y, Xia Q, Chang J, Jiang X, Zhang H. Intratumoral Microbiome of human primary liver Cancer. Hepatol Commun. 2022;6(7):1741\u201352.","journal-title":"Hepatol Commun"},{"issue":"6","key":"727_CR32","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1136\/gutjnl-2017-315084","volume":"68","author":"Z Ren","year":"2019","unstructured":"Ren Z, Li A, Jiang J, Zhou L, Yu Z, Lu H, et al. Gut Microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma. Gut. 2019;68(6):1014\u201323.","journal-title":"Gut"},{"issue":"5","key":"727_CR33","doi-asserted-by":"publisher","first-page":"e0098322","DOI":"10.1128\/spectrum.00983-22","volume":"10","author":"JH Huang","year":"2022","unstructured":"Huang JH, Wang J, Chai XQ, Li ZC, Jiang YH, Li J, et al. The intratumoral bacterial metataxonomic signature of hepatocellular carcinoma. Microbiol Spectr. 2022;10(5):e0098322.","journal-title":"Microbiol Spectr"},{"key":"727_CR34","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/cancers13215421","volume":"13","author":"A Borgognone","year":"2021","unstructured":"Borgognone A, Serna G, Noguera-Julian M, Alonso L, Parera M, Catala-Moll F, et al. Performance of 16S metagenomic profiling in Formalin-Fixed Paraffin-Embedded versus Fresh-Frozen colorectal Cancer tissues. Cancers (Basel). 2021;13:21.","journal-title":"Cancers (Basel)"},{"key":"727_CR35","doi-asserted-by":"publisher","first-page":"106476","DOI":"10.1016\/j.mimet.2022.106476","volume":"196","author":"R Cruz-Flores","year":"2022","unstructured":"Cruz-Flores R, Lopez-Carvallo JA, Caceres-Martinez J, Dhar AK. Microbiome analysis from formalin-fixed paraffin-embedded tissues: current challenges and future perspectives. J Microbiol Methods. 2022;196:106476.","journal-title":"J Microbiol Methods"},{"issue":"6","key":"727_CR36","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.jhep.2019.08.006","volume":"71","author":"J Ricke","year":"2019","unstructured":"Ricke J, Klumpen HJ, Amthauer H, Bargellini I, Bartenstein P, de Toni EN, et al. Impact of combined selective internal radiation therapy and Sorafenib on survival in advanced hepatocellular carcinoma. J Hepatol. 2019;71(6):1164\u201374.","journal-title":"J Hepatol"},{"issue":"2","key":"727_CR37","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1111\/liv.12622","volume":"35","author":"J Ricke","year":"2015","unstructured":"Ricke J, Bulla K, Kolligs F, Peck-Radosavljevic M, Reimer P, Sangro B, et al. Safety and toxicity of radioembolization plus Sorafenib in advanced hepatocellular carcinoma: analysis of the European multicentre trial SORAMIC. Liver Int. 2015;35(2):620\u20136.","journal-title":"Liver Int"},{"issue":"1","key":"727_CR38","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s40168-017-0271-9","volume":"5","author":"S Rath","year":"2017","unstructured":"Rath S, Heidrich B, Pieper DH, Vital M. Uncovering the trimethylamine-producing bacteria of the human gut microbiota. Microbiome. 2017;5(1):54.","journal-title":"Microbiome"},{"issue":"7","key":"727_CR39","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nmeth.3869","volume":"13","author":"BJ Callahan","year":"2016","unstructured":"Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJ, Holmes SP. DADA2: High-resolution sample inference from illumina amplicon data. Nat Methods. 2016;13(7):581\u20133.","journal-title":"Nat Methods"},{"issue":"Database issue","key":"727_CR40","first-page":"D590","volume":"41","author":"C Quast","year":"2013","unstructured":"Quast C, Pruesse E, Yilmaz P, Gerken J, Schweer T, Yarza P, et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 2013;41(Database issue):D590\u20136.","journal-title":"Nucleic Acids Res"},{"key":"727_CR41","doi-asserted-by":"publisher","first-page":"e1602","DOI":"10.7717\/peerj.1602","volume":"4","author":"H Verstraelen","year":"2016","unstructured":"Verstraelen H, Vilchez-Vargas R, Desimpel F, Jauregui R, Vankeirsbilck N, Weyers S, et al. Characterisation of the human uterine Microbiome in non-pregnant women through deep sequencing of the V1-2 region of the 16S rRNA gene. PeerJ. 2016;4:e1602.","journal-title":"PeerJ"},{"issue":"2","key":"727_CR42","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1136\/gutjnl-2016-312904","volume":"67","author":"C Schulz","year":"2018","unstructured":"Schulz C, Schutte K, Koch N, Vilchez-Vargas R, Wos-Oxley ML, Oxley APA, et al. The active bacterial assemblages of the upper GI tract in individuals with and without Helicobacter infection. Gut. 2018;67(2):216\u201325.","journal-title":"Gut"},{"issue":"4","key":"727_CR43","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1053\/j.gastro.2019.05.068","volume":"157","author":"R Vasapolli","year":"2019","unstructured":"Vasapolli R, Schutte K, Schulz C, Vital M, Schomburg D, Pieper DH, et al. Analysis of transcriptionally active Bacteria throughout the Gastrointestinal tract of healthy individuals. Gastroenterology. 2019;157(4):1081\u2013e923.","journal-title":"Gastroenterology"},{"issue":"1","key":"727_CR44","doi-asserted-by":"publisher","first-page":"1966261","DOI":"10.1080\/19490976.2021.1966261","volume":"13","author":"K Schutte","year":"2021","unstructured":"Schutte K, Schulz C, Vilchez-Vargas R, Vasapolli R, Palm F, Simon B, et al. Impact of healthy aging on active bacterial assemblages throughout the Gastrointestinal tract. Gut Microbes. 2021;13(1):1966261.","journal-title":"Gut Microbes"},{"issue":"11","key":"727_CR45","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498\u2013504.","journal-title":"Genome Res"},{"issue":"2","key":"727_CR46","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/bioinformatics\/btm554","volume":"24","author":"Y Assenov","year":"2008","unstructured":"Assenov Y, Ramirez F, Schelhorn SE, Lengauer T, Albrecht M. Computing topological parameters of biological networks. Bioinformatics. 2008;24(2):282\u20134.","journal-title":"Bioinformatics"},{"issue":"1","key":"727_CR47","first-page":"1","volume":"4","author":"\u00d8H Hammer","year":"2001","unstructured":"Hammer \u00d8H, D. A.T. and, Ryan PD, Past. Paleontological statistics software package for education and data analysis. Palaeontologia Electronica. 2001;4(1):1\u20139.","journal-title":"Palaeontologia Electronica"},{"issue":"6494","key":"727_CR48","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1126\/science.aay9189","volume":"368","author":"D Nejman","year":"2020","unstructured":"Nejman D, Livyatan I, Fuks G, Gavert N, Zwang Y, Geller LT, et al. The human tumor Microbiome is composed of tumor type-specific intracellular bacteria. Science. 2020;368(6494):973\u201380.","journal-title":"Science"},{"key":"727_CR49","doi-asserted-by":"publisher","first-page":"102509","DOI":"10.1016\/j.anaerobe.2021.102509","volume":"77","author":"L Boyanova","year":"2022","unstructured":"Boyanova L, Marteva-Proevska Y, Markovska R, Yordanov D, Gergova R. Urinary tract infections: should we think about the anaerobic cocci? Anaerobe. 2022;77:102509.","journal-title":"Anaerobe"},{"key":"727_CR50","doi-asserted-by":"crossref","unstructured":"Rosero JA, Killer J, Sechovcova H, Mrazek J, Benada O, Fliegerova K et al. Reclassification of Eubacterium rectaleHauduroy (1937) Prevot 1938 in a new genus Agathobacter gen. nov. as Agathobacter rectalis comb. nov., and description of Agathobacter ruminis sp. nov., isolated from the rumen contents of sheep and cows. Int J Syst Evol Microbiol. 2016;66(2):768\u2013\u200973.","DOI":"10.1099\/ijsem.0.000788"},{"issue":"5","key":"727_CR51","doi-asserted-by":"publisher","first-page":"762","DOI":"10.3201\/eid2005.130953","volume":"20","author":"SA Shelburne","year":"2014","unstructured":"Shelburne SA, Sahasrabhojane P, Saldana M, Yao H, Su X, Horstmann N, et al. Streptococcus mitis strains causing severe clinical disease in cancer patients. Emerg Infect Dis. 2014;20(5):762\u201371.","journal-title":"Emerg Infect Dis"},{"key":"727_CR52","doi-asserted-by":"crossref","unstructured":"Fujii T, Kuzuya T, Kondo N, Funasaka K, Ohno E, Hirooka Y et al. Altered intestinal Streptococcus anginosus and 5alpha-reductase gene levels in patients with hepatocellular carcinoma and elevated Bacteroides stercoris in atezolizumab\/bevacizumab non-responders. J Med Microbiol. 2024;73(9).","DOI":"10.1099\/jmm.0.001878"},{"issue":"12","key":"727_CR53","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1136\/gutjnl-2024-332815","volume":"73","author":"R Zeng","year":"2024","unstructured":"Zeng R, Gou H, Lau HCH, Yu J. Stomach microbiota in gastric cancer development and clinical implications. Gut. 2024;73(12):2062\u201373.","journal-title":"Gut"},{"issue":"2","key":"727_CR54","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.dld.2007.09.011","volume":"40","author":"W Abu Al-Soud","year":"2008","unstructured":"Abu Al-Soud W, Stenram U, Ljungh A, Tranberg KG, Nilsson HO, Wadstrom T. DNA of Helicobacter spp. And common gut bacteria in primary liver carcinoma. Dig Liver Dis. 2008;40(2):126\u201331.","journal-title":"Dig Liver Dis"},{"issue":"8","key":"727_CR55","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00203-023-03602-z","volume":"205","author":"M Mohammadi","year":"2023","unstructured":"Mohammadi M, Attar A, Mohammadbeigi M, Peymani A, Bolori S, Fardsanei F. The possible role of Helicobacter pylori in liver diseases. Arch Microbiol. 2023;205(8):281.","journal-title":"Arch Microbiol"},{"issue":"1","key":"727_CR56","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/s41598-024-51361-8","volume":"14","author":"CC Liu","year":"2024","unstructured":"Liu CC, Wolf M, Ortego R, Grencewicz D, Sadler T, Eng C. Characterization of Immunomodulating agents from Staphylococcus aureus for priming immunotherapy in triple-negative breast cancers. Sci Rep. 2024;14(1):756.","journal-title":"Sci Rep"},{"issue":"2","key":"727_CR57","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3855\/jidc.9851","volume":"12","author":"R Wilson Dib","year":"2018","unstructured":"Wilson Dib R, Matar M, Hallak R, Farra A, Mokhbat J. Gemella hepatic abscesses: a case report and review of the literature. J Infect Dev Ctries. 2018;12(2):146\u20139.","journal-title":"J Infect Dev Ctries"},{"issue":"2","key":"727_CR58","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/jgf2.497","volume":"23","author":"S Kodaka","year":"2022","unstructured":"Kodaka S, Uchida T, Gomi H. Gemella haemolysans as an emerging pathogen for bacteremia among the elderly. J Gen Fam Med. 2022;23(2):110\u20132.","journal-title":"J Gen Fam Med"},{"issue":"4","key":"727_CR59","first-page":"341","volume":"117","author":"L Abraham","year":"2020","unstructured":"Abraham L, Bamberger DM. Staphylococcus aureus bacteremia: contemporary management. Mo Med. 2020;117(4):341\u20135.","journal-title":"Mo Med"},{"key":"727_CR60","first-page":"100248","volume":"26","author":"R Ono","year":"2023","unstructured":"Ono R, Kitagawa I, Kobayashi Y. Cardiobacterium hominis infective endocarditis: A literature review. Am Heart J Plus. 2023;26:100248.","journal-title":"Am Heart J Plus"},{"issue":"5","key":"727_CR61","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/0732-8893(92)90087-A","volume":"15","author":"J Reina","year":"1992","unstructured":"Reina J, Borrell N, Llompart I. Community-acquired bacteremia caused by Serratia plymuthica. Case report and review of the literature. Diagn Microbiol Infect Dis. 1992;15(5):449\u201352.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"8","key":"727_CR62","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/j.1348-0421.2005.tb03669.x","volume":"49","author":"KS Ko","year":"2005","unstructured":"Ko KS, Lee NY, Oh WS, Lee JH, Ki HK, Peck KR, et al. Tepidimonas arfidensis sp. Nov., a novel Gram-negative and thermophilic bacterium isolated from the bone marrow of a patient with leukemia in Korea. Microbiol Immunol. 2005;49(8):785\u20138.","journal-title":"Microbiol Immunol"},{"issue":"12","key":"727_CR63","doi-asserted-by":"publisher","first-page":"4661","DOI":"10.1128\/JCM.01481-10","volume":"48","author":"XY Han","year":"2010","unstructured":"Han XY, Tarrand JJ, Dickey BF, Esteva FJ. Helicobacter pylori bacteremia with sepsis syndrome. J Clin Microbiol. 2010;48(12):4661\u20133.","journal-title":"J Clin Microbiol"},{"key":"727_CR64","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/1471-2334-14-162","volume":"14","author":"M Mehmood","year":"2014","unstructured":"Mehmood M, Jaffar NA, Nazim M, Khasawneh FA. Bacteremic skin and soft tissue infection caused by Prevotella loescheii. BMC Infect Dis. 2014;14:162.","journal-title":"BMC Infect Dis"},{"issue":"12","key":"727_CR65","doi-asserted-by":"publisher","first-page":"6217","DOI":"10.1128\/JCM.43.12.6217.2005","volume":"43","author":"M Hui","year":"2005","unstructured":"Hui M. Streptococcus anginosus bacteremia: sutton\u2019s law. J Clin Microbiol. 2005;43(12):6217.","journal-title":"J Clin Microbiol"},{"issue":"6","key":"727_CR66","doi-asserted-by":"publisher","first-page":"495","DOI":"10.36518\/2689-0216.1126","volume":"1","author":"AD Lake","year":"2020","unstructured":"Lake AD, Fields R, Guerrero F, Almuzaini Y, Sundaresh K, Staffetti J. Case of Enterococcus cecorum human bacteremia, united States. HCA Healthc J Med. 2020;1(6):495\u20138.","journal-title":"HCA Healthc J Med"},{"issue":"4","key":"727_CR67","doi-asserted-by":"publisher","first-page":"116185","DOI":"10.1016\/j.diagmicrobio.2024.116185","volume":"108","author":"A Blackberg","year":"2024","unstructured":"Blackberg A, Holm K, Liderot K, Nilson B, Sunnerhagen T. Eubacterium bacteremia - a retrospective observational study of a seldom found anaerobic pathogen. Diagn Microbiol Infect Dis. 2024;108(4):116185.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"727_CR68","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.syapm.2017.11.002","volume":"41","author":"M Hilgarth","year":"2018","unstructured":"Hilgarth M, Fuertes S, Ehrmann M, Vogel RF. Photobacterium carnosum sp. nov., isolated from spoiled modified atmosphere packaged poultry meat. Syst Appl Microbiol. 2018;41(1):44\u201350.","journal-title":"Syst Appl Microbiol"},{"issue":"11","key":"727_CR69","doi-asserted-by":"publisher","first-page":"4518","DOI":"10.1099\/ijsem.0.002325","volume":"67","author":"AM Labella","year":"2017","unstructured":"Labella AM, Arahal DR, Lucena T, Manchado M, Castro D, Borrego JJ. Photobacterium Toruni sp. nov., a bacterium isolated from diseased farmed fish. Int J Syst Evol Microbiol. 2017;67(11):4518\u201325.","journal-title":"Int J Syst Evol Microbiol"},{"issue":"8","key":"727_CR70","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s10096-023-04636-3","volume":"42","author":"C Tellapragada","year":"2023","unstructured":"Tellapragada C, Ostlund H, Giske C, Rasmussen M, Berge A. Recurrent bacteremia with Enterococcus faecalis, the clinical findings predicting endocarditis, and genomic characterization of the isolates: a retrospective cohort study. Eur J Clin Microbiol Infect Dis. 2023;42(8):1001\u20139.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5","key":"727_CR71","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.3201\/eid3005.231514","volume":"30","author":"Y Miyamatsu","year":"2024","unstructured":"Miyamatsu Y, Tanizaki R, Yamada S. Sphingobium yanoikuyae bacteremia, Japan. Emerg Infect Dis. 2024;30(5):1060\u20132.","journal-title":"Emerg Infect Dis"},{"issue":"22","key":"727_CR72","first-page":"1026","volume":"32","author":"C Pulcini","year":"2003","unstructured":"Pulcini C, Roth S, Bernard E, Vandenbos F, Bernard JL, Dellamonica P. [Hafnia alvei bacteremia with liver and muscle abscess: a case report]. Presse Med. 2003;32(22):1026\u20137.","journal-title":"Presse Med"},{"issue":"5","key":"727_CR73","doi-asserted-by":"publisher","first-page":"e1005519","DOI":"10.1371\/journal.ppat.1005519","volume":"12","author":"LI McCall","year":"2016","unstructured":"McCall LI, Siqueira-Neto JL, McKerrow JH, Location. Location, location: five facts about tissue tropism and pathogenesis. PLoS Pathog. 2016;12(5):e1005519.","journal-title":"PLoS Pathog"},{"key":"727_CR74","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.bdq.2018.10.001","volume":"16","author":"XJD Lu","year":"2018","unstructured":"Lu XJD, Liu KYP, Zhu YS, Cui C, Poh CF. Using DdPCR to assess the DNA yield of FFPE samples. Biomol Detect Quantif. 2018;16:5\u201311.","journal-title":"Biomol Detect Quantif"},{"key":"727_CR75","doi-asserted-by":"publisher","first-page":"106902","DOI":"10.1016\/j.aquatox.2024.106902","volume":"270","author":"NS Kiran","year":"2024","unstructured":"Kiran NS, Yashaswini C, Chatterjee A, Zebrafish. A trending model for gut-brain axis investigation. Aquat Toxicol. 2024;270:106902.","journal-title":"Aquat Toxicol"},{"key":"727_CR76","doi-asserted-by":"publisher","first-page":"122311","DOI":"10.1016\/j.lfs.2023.122311","volume":"336","author":"NS Kiran","year":"2024","unstructured":"Kiran NS, Yashaswini C, Chatterjee A. Noxious ramifications of cosmetic pollutants on Gastrointestinal microbiome: A pathway to neurological disorders. Life Sci. 2024;336:122311.","journal-title":"Life Sci"},{"issue":"6","key":"727_CR77","first-page":"e8852","volume":"12","author":"M Elnaggar","year":"2020","unstructured":"Elnaggar M, Mahboob S, Beutler BD, Hanfy A, Canaday O. Streptococcus mitis abscesses mimicking liver metastases. Cureus. 2020;12(6):e8852.","journal-title":"Cureus"},{"key":"727_CR78","doi-asserted-by":"publisher","first-page":"100435","DOI":"10.1016\/j.phanu.2025.100435","volume":"31","author":"M Abavisani","year":"2025","unstructured":"Abavisani M, Foroushan SK, Kesharwani P, Sahebkar A. The frontier of health: exploring therapeutic potentials of the Microbiome. PharmaNutrition. 2025;31:100435.","journal-title":"PharmaNutrition"},{"key":"727_CR79","doi-asserted-by":"publisher","first-page":"1104399","DOI":"10.3389\/fcimb.2022.1104399","volume":"12","author":"K Shi","year":"2022","unstructured":"Shi K, Zhang Q, Zhang Y, Bi Y, Zeng X, Wang X. Association between probiotic therapy and the risk of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis. Front Cell Infect Microbiol. 2022;12:1104399.","journal-title":"Front Cell Infect Microbiol"},{"issue":"9","key":"727_CR80","doi-asserted-by":"publisher","first-page":"E1306","DOI":"10.1073\/pnas.1518189113","volume":"113","author":"J Li","year":"2016","unstructured":"Li J, Sung CY, Lee N, Ni Y, Pihlajamaki J, Panagiotou G, et al. Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice. Proc Natl Acad Sci U S A. 2016;113(9):E1306\u201315.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Gut Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-025-00727-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13099-025-00727-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-025-00727-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T05:33:04Z","timestamp":1757223184000},"score":1,"resource":{"primary":{"URL":"https:\/\/gutpathogens.biomedcentral.com\/articles\/10.1186\/s13099-025-00727-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["727"],"URL":"https:\/\/doi.org\/10.1186\/s13099-025-00727-y","relation":{},"ISSN":["1757-4749"],"issn-type":[{"value":"1757-4749","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,10]]},"assertion":[{"value":"4 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The SORAMIC trial (EudraCT 2009-012576-27, NCT01126645) was approved by the institutional review boards of all 38 participating centers and was conducted according to the ethical principles expressed in the Declaration of Helsinki. Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"CS has received honoraria for lectures from Juvis\u00e9 Pharmaceutics, Astellas and the Falk Foundation. CS has served in the Data Safety Monitoring Board or Advisory Board from Sanofi, Astella and Juvis\u00e9 Pharmaceutics. CV has received consulting fees from IPSEN, AstraZeneca and Bayer and has received honoraria for lectures from IPSEN and Astra Zeneca.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"53"}}